Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis.

被引：0
|
作者：
Combe, BG
Codreanu, C
Fiocco, U
Gaubitz, M
Geusens, PP
Kvien, TK
Pavelka, K
Sambrook, PN
Smolen, JS
Williams, BD
Appel, A
机构：
[1] H Lapeyron, Montpellier, France
[2] C Metod Reumat, Bucharest, Romania
[3] Clin Osp, Padua, Italy
[4] Univ Munster, D-4400 Munster, Germany
[5] Limburgs Univ Ctr, Diepenbeek, Belgium
[6] Dia Syk, Oslo, Norway
[7] Inst Rheumatol, Prague, Czech Republic
[8] RNSH, St Leonards, NSW, Australia
[9] Hos Vien, Vienna, Austria
[10] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales
[11] Wyeth Res, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S517 / S517
页数：1
相关论文
共 50 条
  • [21] SULFASALAZINE IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    PINALS, RS
    KAPLAN, SB
    LAWSON, JG
    HEPBURN, B
    ARTHRITIS AND RHEUMATISM, 1986, 29 (12): : 1427 - 1434
  • [22] A Double-Blind Randomized Placebo-Controlled Trial Of Lovastatin in Patients with Rheumatoid Arthritis.
    Aranow, Cynthia
    Cush, John J.
    Bolster, Marcy B.
    Striebich, Christopher C.
    Dall'Era, Maria
    Mackay, Meggan
    Olech, Ewa
    Frech, Tracy M.
    Box, J.
    Keating, Richard M.
    Wasko, Mary Chester M.
    St Clair, E. William
    Kivitz, Alan
    Diamond, Betty
    Davidson, Anne
    Spychala, Meagan
    Goldmuntz, Ellen A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1181 - S1182
  • [23] DOUBLE-BLIND COMPARISON OF ETODOLAC AND DICLOFENAC IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    LONAUER, G
    TISSCHER, JR
    LIM, HG
    BIJLSMA, JWJ
    CURRENT MEDICAL RESEARCH AND OPINION, 1993, 13 (02) : 70 - 77
  • [24] DOUBLE-BLIND COMPARISON OF ETODOLAC AND PIROXICAM IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SCHATTENKIRCHNER, M
    CURRENT MEDICAL RESEARCH AND OPINION, 1991, 12 (08) : 497 - 506
  • [25] Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis - Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial
    van der Heijde, D
    Klareskog, L
    Rodriguez-Valverde, V
    Codreanu, C
    Bolosiu, H
    Melo-Gomes, J
    Tornero-Molina, J
    Wajdula, J
    Pedersen, R
    Fatenejad, S
    ARTHRITIS AND RHEUMATISM, 2006, 54 (04): : 1063 - 1074
  • [26] Enbrel® (etanercept) pharmacokinetics in patients with rheumatoid arthritis.
    Kremer, JM
    Spencer-Green, GT
    Hanna, RK
    Korth-Bradley, JM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S229 - S229
  • [27] Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
    Klareskog, L
    van der Heijde, D
    de Jager, JP
    Gough, A
    Kalden, J
    Malaise, M
    Mola, EM
    Pavelka, K
    Sany, J
    Settas, L
    Wajdula, J
    Pedersen, R
    Fatenejad, S
    Sanda, M
    LANCET, 2004, 363 (9410): : 675 - 681
  • [28] DOUBLE-BLIND COMPARISON OF NAPROXEN AND INDOMETHACIN IN RHEUMATOID ARTHRITIS
    SZANTO, E
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1974, 3 (03) : 118 - 120
  • [29] A randomized double-blind controlled study evaluating the safety and efficacy of etanercept vs etanercept plus anakinra in patients with rheumatoid arthritis
    Genovese, MC
    Cohen, SB
    Moreland, LW
    Lium, D
    Liu, T
    Newmark, R
    Bekker, P
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 66 - 66
  • [30] A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: A 12-week, double-blind, randomized, placebo-controlled study
    Lan, JL
    Chou, SJ
    Chen, DY
    Chen, YH
    Hsieh, TY
    Young, M
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (08) : 618 - 623
12345